|
LXRX Lexicon Pharmaceuticals Inc 1062822 |
| Balance Sheet |
|
Current Assets
|
246,193,000 |
|
Assets
|
298,420,000 |
|
Current Liabilities
|
45,248,000 |
|
Liabilities
|
152,470,000 |
|
Equity
|
145,950,000 |
|
Shares Out
|
361,492,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-178,780,000 |
|
Investing Cash Flow
|
-15,378,000 |
| Market Analysis |
Market Cap
|
582,002,447 |
|
Price
|
0.34 |
|
BVPS
|
0.40 |
|
PB
|
0.84 |
|
EPS
|
-0.78 |
|
PS
|
24.25 |
|
FCF
|
-194,158,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LXRX documents filed with the SEC.
LXRX Filings
Clear
